View Ultrafen overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity. Asthmatic patient & in whom attacks of asthma, urticaria or acute rhinitis are precipitated by aspirin or other NSAIDs. Established CV disease (CHF, established ischemic heart disease, peripheral arterial disease) or uncontrolled HTN at high dose (150 mg/day) use for >4 wk.
History of peptic ulcer, hematemesis, melena, bleeding diathesis or w/ severe hepatic or renal insufficiency. Discontinue use if abnormal liver function tests persist or worsen, clinical signs & symptoms consistent w/ liver disease develop or eosinophilia, rash occur. Hepatic porphyria. Increased risk of serious CV thrombotic events (MI & stroke) in high dose or long-term treatment. Periodically re-evaluate patient's need for symptomatic relief & response to therapy especially when treatment continues for >4 wk. Remain alert for sign & symptoms of serious arteriothrombotic events (eg, chest pain, shortness of breath, weakness, slurring of speech). Pregnancy.
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Sign Out
